ConvaTec Group PLC
PublicConvaTec Group PLC is now publicly traded
The data on this page reflects ConvaTec Group PLC's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 26, 2016
Last Round
Debt
Sep 30, 2021
Total Funding Raised
$7.3B
Company Overview
ConvaTec Group PLC is a global medical products and technologies company that develops, manufactures, and markets solutions for chronic conditions. The company's main business areas are Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Originally a division of E.R. Squibb & Sons, Inc. (later part of Bristol-Myers Squibb), ConvaTec was established in 1978. It became an independent entity and was listed on the London Stock Exchange in 2016. The company's products include advanced dressings for acute and chronic wounds, devices and accessories for people with a stoma, products for urinary continence issues, and disposable infusion sets for insulin pump therapy. ConvaTec operates globally, serving hospitals, homecare agencies, and distributors in approximately 90 countries.
AI Layer
Non-AI
Keywords
ConvaTec Group PLC Comparables
Compare ConvaTec Group PLC with similar companies based on industry and business-model similarity.
ConvaTec Group PLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 30, 2021 | ||||
| IPO | Oct 26, 2016 | ||||
| Debt | Aug 12, 2013 | ||||
| Buyout/LBO | Aug 1, 2008 |
ConvaTec Group PLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mitsubishi UFJ Financial Group | Debt |
| Mizuho Securities | Debt |
| Goldman Sachs Bank Europe SE | Debt |
| Nordic Capital | IPO, Buyout/LBO |
| Bank of America Merrill Lynch | IPO |
| NatWest Markets | Debt |
| DNB Markets | Debt |
ConvaTec Group PLC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |